UBS Group »

Arcturus Therapeutics Hldg I shares owned by UBS Group

Quarter-by-quarter ownership of Arcturus Therapeutics Hldg I (ARCT) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Arcturus Therapeutics Hldg I

Tip: Access up to 7 years of quarterly data

All positions including Arcturus Therapeutics Hldg I held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcturus Therapeutics Hldg I by UBS Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.6M 108k 33.77
2023-12-31 $2.3M 73k 31.53
2023-09-30 $799k 31k 25.55
2023-06-30 $488k 17k 28.69
2023-03-31 $988k 41k 23.97
2022-12-31 $1.4M 85k 16.96
2022-09-30 $52k 3.5k 14.94
2022-06-30 $584k 37k 15.84
2022-03-31 $5.4M 202k 26.94
2021-12-31 $3.7M 99k 37.03
2021-09-30 $4.3M 90k 47.78
2021-06-30 $1.1M 34k 33.83
2021-03-31 $1.8M 43k 41.29
2020-12-31 $1.2M 28k 43.64
2020-09-30 $598k 14k 42.90
2020-06-30 $743k 16k 46.75
2020-03-31 $3.0k 249 12.05
2019-12-31 $6.0k 557 10.77
2019-06-30 $28k 2.9k 9.59